iBio (IBIO) EBT (2016 - 2025)
Historic EBT for iBio (IBIO) over the last 17 years, with Q4 2025 value amounting to -$9.0 million.
- iBio's EBT fell 10607.24% to -$9.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$24.7 million, marking a year-over-year decrease of 6238.02%. This contributed to the annual value of -$18.4 million for FY2025, which is 1176.18% down from last year.
- Per iBio's latest filing, its EBT stood at -$9.0 million for Q4 2025, which was down 10607.24% from -$5.7 million recorded in Q3 2025.
- iBio's 5-year EBT high stood at -$3.2 million for Q2 2024, and its period low was -$10.6 million during Q4 2022.
- Its 5-year average for EBT is -$6.3 million, with a median of -$5.8 million in 2021.
- Per our database at Business Quant, iBio's EBT crashed by 18508.9% in 2021 and then skyrocketed by 5751.21% in 2023.
- iBio's EBT (Quarter) stood at -$7.2 million in 2021, then tumbled by 46.79% to -$10.6 million in 2022, then soared by 57.51% to -$4.5 million in 2023, then grew by 2.76% to -$4.4 million in 2024, then crashed by 106.07% to -$9.0 million in 2025.
- Its last three reported values are -$9.0 million in Q4 2025, -$5.7 million for Q3 2025, and -$5.2 million during Q2 2025.